Bratati Karmakar 38th Lorne Cancer Conference 2026

Abstracts this author is presenting:

• A phase I/II study to assess the toxicity and preliminary efficacy of SUBA-itraconazole and dual checkpoint inhibitor cadonilimab as maintenance therapy in advanced pancreatic ductal adenocarcinoma — Welcome Reception & Poster Session 1